Sunshine Biopharma, Inc | Uncategorized | Business Contracts

Placement Agent Agreement dated May 12, 2023 (Filed With SEC on May 16, 2023)

Research Agreement between the Company and JGH (Filed With SEC on February 10, 2023)

Engagement Letter dated April 25, 2022 (Filed With SEC on April 28, 2022)

Description of Registrants Securities (Filed With SEC on March 21, 2022)

Engagement Letter dated March 9, 2022, as amended (Filed With SEC on March 15, 2022)

Research Agreement, dated February 18, 2022, between the Company and the University (Filed With SEC on February 25, 2022)

Sponsored Research Agreement, dated October 6, 2020, between the Company and the University of Georgia Research Foundation, Inc (Filed With SEC on January 24, 2022)

Registration Rights Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)

Equity Financing Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)

Promissory Note issued by Sunshine Biopharma, Inc. in favor of GHS Investments LLC (Filed With SEC on September 14, 2018)

AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016 (Filed With SEC on March 14, 2016)

Patent Purchase Agreement with Advanomics Corporation (Filed With SEC on December 28, 2015)

PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of October 8, 2015 PATENT PURCHASE AGREEMENT (Filed With SEC on October 9, 2015)

INVESTMENT AGREEMENT (Filed With SEC on April 28, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2014)

AMENDMENT 2 TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 27, 2011)

Sunshine Biopharma, Inc (44) | Uncategorized (17)